The China Securities Regulatory Commission issued new guidelines requiring more stringent ESG criteria for funds marketing themselves as sustainable investments, effective from Q4 2025.

Chinese healthcare and pharmaceutical funds dominated Q3 2025 performance rankings, with average returns of 18.3% driven by strong innovation pipeline and aging population trends.

Major Chinese QDII fund managers are increasing exposure to Southeast Asian and Latin American markets, seeking diversification opportunities beyond traditional developed market allocations.

Chinese bond funds attracted ¥45 billion in net inflows this week as investors position for potential monetary policy easing, with duration-focused strategies gaining favor.

A survey of 50 leading Chinese fund managers reveals increased optimism for Q4 2025, with 78% expecting positive returns driven by economic stimulus measures and corporate earnings growth.

Updated custody regulations require enhanced segregation of fund assets and improved transparency in custodial operations, effective from January 2026.